Charles Dumontet

Person

Villeurbanne Cedex, FR

People

Patents Grantslast 30 patents

Information Patent Grant
Chalcone derivatives having an anti-allergic activity
- Patent number 9,896,415
- Issue date Feb 20, 2018
- Universite Claude Bernard Lyon I
- Charles Dumontet
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
5′-nucleotidase inhibitors and therapeutic uses thereof
- Patent number 9,783,541
- Issue date Oct 10, 2017
- Centre National de la Recherche Scientifique CNRS
- Laurent Chaloin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
Bispecific T cell activating antigen binding molecules
- Publication number 20170114146
- Publication date Apr 27, 2017
- HOFFMANN-LA ROCHE INC.
- Christian Klein
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
5'-NUCLEOTIDASE INHIBITORS AND THERAPEUTIC USES THEREOF
- Publication number 20160272643
- Publication date Sep 22, 2016
- Centre National de la Recherche Scientifique-CNRS
- Laurent Chaloin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NOVEL CHALCONE DERIVATIVES HAVING AN ANTI-ALLERGIC ACTIVITY
- Publication number 20160052881
- Publication date Feb 25, 2016
- UNIVERSITE CLAUDE BERNARD LYON I
- Charles DUMONTET
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMBINATION THERAPY OF A TYPE II ANTI-CD20 ANTIBODY WITH INCREASED...
- Publication number 20160000911
- Publication date Jan 7, 2016
- Roche Glycart AG
- CHARLES DUMONTET
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION THERAPY OF A TYPE II ANTI-CD20 ANTIBODY WITH INCREASED...
- Publication number 20140065134
- Publication date Mar 6, 2014
- Roche Glycart AG
- CHARLES DUMONTET
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NOVEL AZACOUMARIN DERIVATIVES HAVING MDR PUMP INHIBITING ACTIVITY
- Publication number 20140038883
- Publication date Feb 6, 2014
- UNIVERSITE CLAUDE BERNARD LYON 1
- Anne Doleans-Jordheim
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
COMBINATION THERAPY OF A TYPE II ANTI-CD20 ANTIBODY WITH INCREASED...
- Publication number 20120301459
- Publication date Nov 29, 2012
- HOFFMAN-LA ROCHE INC.
- Charles Dumontet
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION OF A TLR3 LIGAND AND A CHEMOTHERAPY AGENT WHICH ACTS ON...
- Publication number 20120045523
- Publication date Feb 23, 2012
- UNIVERSITE CLAUDE BERNARD LYON I
- Serge Lebecque
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION THERAPY OF A TYPE II ANTI-CD20 ANTIBODY WITH INCREASED...
- Publication number 20110177067
- Publication date Jul 21, 2011
- Hoffman-La Roche, Inc.
- Charles Dumontet
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION THERAPY OF A TYPE II ANTI-CD20 ANTIBODY WITH INCREASED...
- Publication number 20100310581
- Publication date Dec 9, 2010
- HOFFMAN-LA ROCHE INC.
- Charles Dumontet
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION THERAPY OF A TYPE II ANTI-CD20 ANTIBODY WITH INCREASED...
- Publication number 20090246197
- Publication date Oct 1, 2009
- CHARLES DUMONTET
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Novel Chalcone Derivatives With Antimitotic Activity
- Publication number 20090182058
- Publication date Jul 16, 2009
- Ahcene Boumendjel
- C07 - ORGANIC CHEMISTRY

Charles Dumontet

Person

Patents Grantslast 30 patents

Chalcone derivatives having an anti-allergic activity

5′-nucleotidase inhibitors and therapeutic uses thereof

Patents Applicationslast 30 patents

Bispecific T cell activating antigen binding molecules

5'-NUCLEOTIDASE INHIBITORS AND THERAPEUTIC USES THEREOF

NOVEL CHALCONE DERIVATIVES HAVING AN ANTI-ALLERGIC ACTIVITY

COMBINATION THERAPY OF A TYPE II ANTI-CD20 ANTIBODY WITH INCREASED...

COMBINATION THERAPY OF A TYPE II ANTI-CD20 ANTIBODY WITH INCREASED...

NOVEL AZACOUMARIN DERIVATIVES HAVING MDR PUMP INHIBITING ACTIVITY

COMBINATION THERAPY OF A TYPE II ANTI-CD20 ANTIBODY WITH INCREASED...

COMBINATION OF A TLR3 LIGAND AND A CHEMOTHERAPY AGENT WHICH ACTS ON...

COMBINATION THERAPY OF A TYPE II ANTI-CD20 ANTIBODY WITH INCREASED...

COMBINATION THERAPY OF A TYPE II ANTI-CD20 ANTIBODY WITH INCREASED...

COMBINATION THERAPY OF A TYPE II ANTI-CD20 ANTIBODY WITH INCREASED...

Novel Chalcone Derivatives With Antimitotic Activity